Skip to main content

Advertisement

Myelodysplastic Syndromes
Excellence Forum

Advertisement

Advertisement

ADVERTISEMENT

Myelodysplastic Syndrome Excellence Forum

Pinkal Desai, MD
Videos
07/28/2024
Pinkal Desai, MD, discusses risk stratification, restructured disease classifications, and current treatment options for patients with low and intermediate-risk myelodysplastic syndrome at the 2024 Great Debates & Updates meeting.
Pinkal Desai, MD, discusses risk stratification, restructured disease classifications, and current treatment options for patients with low and intermediate-risk myelodysplastic syndrome at the 2024 Great Debates & Updates meeting.
Pinkal Desai, MD, discusses risk...
07/28/2024
Oncology
Aditi Shastri, MD, Montefiore Einstein Comprehensive Cancer Center
Videos
07/17/2024
Aditi Shastri, MD, discusses the treatment regimen she chose for an older patient with lower-risk, ringed sideroblastic negative myelodysplastic syndrome.
Aditi Shastri, MD, discusses the treatment regimen she chose for an older patient with lower-risk, ringed sideroblastic negative myelodysplastic syndrome.
Aditi Shastri, MD, discusses the...
07/17/2024
Oncology
Areej El-Jawahri, MD, Massachusetts General Hospital
Conference Coverage
06/01/2024

Featuring Areej El-Jawahri, MD

Featuring Areej El-Jawahri, MD ...
Areej El-Jawahri MD, discusses trial results that showed palliative care significantly improved the rates of discussion and documentation of end-of-life care preferences, reduced hospitalization, and improved quality of life for patients with...
Areej El-Jawahri MD, discusses trial results that showed palliative care significantly improved the rates of discussion and documentation of end-of-life care preferences, reduced hospitalization, and improved quality of life for patients with...
Areej El-Jawahri MD, discusses...
06/01/2024
Oncology
Aditi Shastri, MD, Montefiore Einstein Comprehensive Cancer Center
Conference Coverage
04/10/2024

Featuring Aditi Shastri, MD

Featuring Aditi Shastri, MD
During the 2024 Great Debates & Updates in Hematological Malignancies Meeting, Aditi Shastri, MD, shares expert insight on recent updates in risk stratification and treatment regimens for patients with low to intermediate risk myelodysplastic...
During the 2024 Great Debates & Updates in Hematological Malignancies Meeting, Aditi Shastri, MD, shares expert insight on recent updates in risk stratification and treatment regimens for patients with low to intermediate risk myelodysplastic...
During the 2024 Great Debates &...
04/10/2024
Oncology
Benjamin Tomlinson, MD, Seidman Cancer Center
Videos
02/29/2024

Featuring Benjamin Tomlinson, MD

Featuring Benjamin Tomlinson, MD ...
Benjamin Tomlinson, MD, explains the course of treatment he selected for a 49-year-old patient with myelodysplastic syndrome with isolated deletion of 5q.
Benjamin Tomlinson, MD, explains the course of treatment he selected for a 49-year-old patient with myelodysplastic syndrome with isolated deletion of 5q.
Benjamin Tomlinson, MD, explains...
02/29/2024
Oncology
Guillermo Garcia-Manero, MD
Videos
10/10/2023

Featuring Guillermo Garcia-Manero, MD

Featuring Guillermo Garcia-Manero, MD...
More patients achieved transfusion-independence and an increase in hemoglobin levels with luspatercept versus epoetin alfa, according to data presented at the SOHO 2023 annual meeting by Guillermo Garcia-Manero, MD.
More patients achieved transfusion-independence and an increase in hemoglobin levels with luspatercept versus epoetin alfa, according to data presented at the SOHO 2023 annual meeting by Guillermo Garcia-Manero, MD.
More patients achieved...
10/10/2023
Oncology
Amer Zeidan, MBBS
Videos
08/19/2023

Featuring Amer Zeidan, MBBS

Featuring Amer Zeidan, MBBS
At the 2023 Great Debates & Updates in Hematologic Malignancies Meeting, Amer Zeidan, MBBS, speaks on recent developments in risk stratification and treatment management among patients with high-risk and low-risk myelodysplastic syndromes.
At the 2023 Great Debates & Updates in Hematologic Malignancies Meeting, Amer Zeidan, MBBS, speaks on recent developments in risk stratification and treatment management among patients with high-risk and low-risk myelodysplastic syndromes.
At the 2023 Great Debates &...
08/19/2023
Oncology
Amer Zeidan Yale Cancer Center
Videos
04/26/2023
At the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, New York, Amer Zeidan, MBBS, MHS, discussed effective risk stratification among patients with myelodysplastic syndromes.
At the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, New York, Amer Zeidan, MBBS, MHS, discussed effective risk stratification among patients with myelodysplastic syndromes.
At the 2023 Great Debates &...
04/26/2023
Oncology
Koen van Besien, MD
Videos
03/13/2023
Koen W. van Besien, MD, recaps a debate in which he argued that patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) and TP53 mutations should undergo allogeneic stem cell transplantation.
Koen W. van Besien, MD, recaps a debate in which he argued that patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) and TP53 mutations should undergo allogeneic stem cell transplantation.
Koen W. van Besien, MD, recaps a...
03/13/2023
Oncology
Dr Lee
Videos
11/29/2021
Sangmin Lee, MD, highlights the current treatment landscape for patients with MDS, including novel therapies that are in development in combination with hypomethylating agents.
Sangmin Lee, MD, highlights the current treatment landscape for patients with MDS, including novel therapies that are in development in combination with hypomethylating agents.
Sangmin Lee, MD, highlights the...
11/29/2021
Oncology

Advertisement

Advertisement

Advertisement

Advertisement